Maxalt-mlt and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Maxalt-mlt (rizatriptan benzoate), especially for people who are female, 50-59 old, also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Maxalt-mlt. It is created by eHealthMe based on reports of 1,245 people who have side effects when taking Maxalt-mlt from the FDA, and is updated regularly.

What is Maxalt-mlt?

Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,405 drugs and 2,776 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 30, 2026

1,245 people reported to have side effects when taking Maxalt-mlt.
Among them, 22 people (1.77%) have Sinusitis - acute.

Could Maxalt-mlt cause Sinusitis - acute?

Among these 22 people:

What is the gender of people who have Sinusitis - acute when taking Maxalt-mlt? *

female: 100 %
male: 0.0 %

What is the age of people who have Sinusitis - acute when taking Maxalt-mlt? *

What are other drugs people take besides Maxalt-mlt? *

What are other side effects people have besides Sinusitis - acute? *

Hypersensitivity: 5 people, 22.73%
Weight Decreased: 5 people, 22.73%
Memory Loss: 5 people, 22.73%
Dyspnea (difficult or laboured breathing): 5 people, 22.73%
Pain: 4 people, 18.18%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 4 people, 18.18%
Sinus Disorder (disease of sinus): 4 people, 18.18%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 13.64%
Dizziness: 3 people, 13.64%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 13.64%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 45.45%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 22.73%
Hereditary Angioedema (recurrent episodes of severe swelling): 3 people, 13.64%
Asthma: 3 people, 13.64%
Immune System Disorder: 3 people, 13.64%
Drowsiness: 3 people, 13.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Headache (pain in head): 2 people, 9.09%
Pain: 2 people, 9.09%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Maxalt-mlt and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maxalt-mlt:

Maxalt-mlt (1,534 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,405 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rizatriptan benzoate (the active ingredients of Maxalt-mlt) and Maxalt-mlt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.